Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BioNTech SE - ADR (BNTX) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance

BioNTech SE - ADRTrade
iShares Broad USD Investment Grade Corporate BondTrade

Price performance (Past 24H)

Key statistics

BioNTech SE - ADR vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.21. The key difference: BioNTech SE - ADR is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.

BNTXUSIG
Market Cap
$23.31B
Sector
HealthFixed Income
52-Week High
$119.34$52.69
52-Week Low
$83.89$50.18
Enterprise Value
$6.60B

Returns comparison

Trailing returns across standard periods

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX

About iShares Broad USD Investment Grade Corporate Bond

USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.

Read more on USIG